Cardinal, Jefferies

Cardinal Health raised to buy by Jefferies
Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
Jefferies Upgrades Cardinal Health (CAH)
Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy. Analyst Price Forecast Suggests 10.48% Upside As of January 29, 2025, the average one-year price target for Cardinal Health is $138.
Cardinal Health upgraded to Buy from Hold at Jefferies
Jefferies analyst Brian Tanquilut upgraded Cardinal Health (CAH) to Buy from Hold with a price target of $150, up from $140. The firm thinks
Cardinal Health Analysts Raise Their Forecasts Following Upbeat Earnings
Wells Fargo analyst Stephen Baxter maintained Cardinal Health with an Equal-Weight and raised the price target from $135 to $136. JP Morgan analyst Lisa Gill maintained Cardinal Health with a Neutral and raised the price target from $142 to $145.
Cardinal Health may raise prices to offset potential tariffs
Drug distributor Cardinal Health said on Thursday it may need to increase prices of some of its products if the proposed tariffs on Mexico go into effect, to counter increasing costs of manufacturing in the region.
Cardinal Health price target raised to $136 from $135 at Wells Fargo
Wells Fargo raised the firm’s price target on Cardinal Health (CAH) to $136 from $135 and keeps an Equal Weight rating on the shares. The firm
Cardinal Health Inc. stock outperforms competitors on strong trading day
Shares of Cardinal Health Inc. CAH advanced 1.82% to $127.45 Wednesday, on what proved to be an all-around great trading ...
Wells Fargo & Company Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price
Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...
Cardinal Health CEO: Here's why tariffs don't always lead to reshoring
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Cardinal Health raises FY25 EPS guidance to $7.85-$8 amid specialty growth and acquisitions
Q2 2025 Management View CEO Jason Hollar emphasized strong Q2 performance driven by robust demand in Pharmaceutical and ...
Dublin City Schools cancels plan to buy Cardinal Health building for $37 million
Draped in Mexican and Salvadoran flags, roughly 1,000 demonstrators gathered near City Hall shortly before noon, blocking ...
MDM6d
Cardinal Health 2Q Sales Rise 16% Outside of Optimum Impact
Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...
Largest borrow rate increases among liquid names
Latest data shows the largest indicative borrow rate increases among liquid option names include: Sellas Life Sciences (SLS) 69.57% +2.56, ...
Cardinal Health Inc (CAH) Q2 2025 Earnings Call Highlights: Strong Pharma Growth Amid Revenue ...
Cardinal Health Inc (CAH) raises EPS guidance despite a 4% revenue decline, driven by robust pharmaceutical segment ...